Delayed cutaneous hypersensitivity in patients with prostatic adenocarcinoma.
暂无分享,去创建一个
[1] W. Catalona,et al. Abnormalities of cell-mediated immunocompetence in genitourinary cancer. , 1974, The Journal of urology.
[2] R. Gittes,et al. Immunologic competence in patients with urologic cancer. , 1974, The Journal of urology.
[3] C. Olsson,et al. Immunologic reduction of bladder cancer recurrence rate. , 1974, Transactions of the American Association of Genito-Urinary Surgeons.
[4] W. Catalona,et al. Correlation among host immunocompetence and tumor stage, tumor grade and vascular permeation in transitional carcinoma. , 1973, Journal of Urology.
[5] D. Morton. Immunotherapy of cancer. Present Status and Future Potential , 1972, Cancer.
[6] W. Catalona,et al. Quantitative dinitrochlorobenzene contact sensitization in a normal population. , 1972, Clinical and experimental immunology.
[7] H. Sjögren,et al. Demonstration of cell‐mediated immunity to human neoplasms of various histological types , 1971, International journal of cancer.
[8] W. Frable,et al. Cervical dysplasia and cancer developing in women on immunosuppression therapy for renal homotransplantation , 1970 .
[9] T. Starzl,et al. Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). , 1970, Annals of surgery.
[10] D. Morton,et al. Impaired immunologic reactivity and recurrence following cancer surgery , 1970, Cancer.
[11] J. Alexander,et al. Immunobiology for Surgeons , 1970 .